Free Trial

Cartesian Therapeutics (RNAC) Institutional Ownership

Cartesian Therapeutics logo
$9.51 0.00 (0.00%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$9.58 +0.07 (+0.74%)
As of 06/12/2026 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Cartesian Therapeutics (NASDAQ:RNAC)

Current
Institutional Ownership
Percentage
86.95%
Number of
Institutional Buyers
(last 12 months)
21
Total
Institutional Inflows
(last 12 months)
$7.43M
Number of
Institutional Sellers
(last 12 months)
9
Total
Institutional Outflows
(last 12 months)
$3.56M
Get RNAC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

RNAC Institutional Buying and Selling by Quarter

Cartesian Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026 Renaissance Technologies LLC67,300$414K0.0%+63.7%0.229%
5/14/2026 Public Employees Retirement System of Ohio13,000$80K0.0%-16.1%0.044%
5/14/2026 Sei Investments Co.12,764$78K0.0%N/A0.043%
2/18/2026 XTX Topco Ltd10,238$74K0.0%-61.0%0.039%
2/18/2026 Millennium Management LLC164,366$1.19M0.0%+548.2%0.632%
2/18/2026 683 Capital Management LLC280,000$2.02M0.1%+21.7%1.077%
2/17/2026 Jain Global LLC16,724$121K0.0%N/A0.064%
2/17/2026 Public Employees Retirement System of Ohio15,500$112K0.0%N/A0.060%
2/16/2026 Squarepoint Ops LLC18,213$131K0.0%N/A0.070%
2/13/2026 Marshall Wace LLP178,140$1.28M0.0%+110.1%0.685%
2/13/2026 Walleye Capital LLC43,878$316K0.0%N/A0.169%
2/13/2026 Wells Fargo & Company MN11,762$85K0.0%+49.2%0.045%
2/12/2026 Renaissance Technologies LLC41,100$296K0.0%N/A0.158%
2/12/2026 Miller Financial Services LLC13,643$98K0.1%+17.2%0.052%
2/11/2026 Erste Asset Management GmbH271,705$1.96M0.0%+4.5%1.045%
2/9/2026 Geode Capital Management LLC255,539$1.84M0.0%+5.7%0.983%
2/3/2026 Privium Fund Management B.V.172,500$1.24M0.2%N/A0.663%
1/30/2026 R Squared Ltd10,308$74K0.0%N/A0.040%
11/17/2025 Jacobs Levy Equity Management Inc.30,001$307K0.0%-27.4%0.115%
11/17/2025 Millennium Management LLC25,357$259K0.0%N/A0.098%
11/14/2025 Bridgeway Capital Management LLC25,000$256K0.0%N/A0.096%
11/7/2025 GSA Capital Partners LLP86,095$880K0.1%+106.9%0.331%
11/7/2025Vanguard Group Inc.520,722$5.32M0.0%+4.9%2.003%
11/3/2025 AlphaQuest LLC6,924$71K0.0%+64.6%0.027%
8/15/2025 Bank of America Corp DE13,933$145K0.0%+133.0%0.054%
8/15/2025 683 Capital Management LLC219,000$2.28M0.1%+46.0%0.842%
8/14/2025 MPM Bioimpact LLC686,007$7.13M1.2%-13.2%2.638%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,056$53K0.0%-16.0%0.019%
8/13/2025 Marshall Wace LLP82,630$859K0.0%+114.0%0.318%
8/13/2025 Virtus Investment Advisers LLC9,183$95K0.0%+12.5%0.035%
8/12/2025 JPMorgan Chase & Co.6,080$63K0.0%-96.9%0.023%
8/12/2025 Miller Financial Services LLC11,643$121K0.2%N/A0.045%
8/8/2025 Geode Capital Management LLC218,927$2.28M0.0%-2.9%0.844%
7/31/2025 AlphaQuest LLC4,207$44K0.0%-41.5%0.016%
6/27/2025 Goldman Sachs Group Inc.15,775$208K0.0%-42.7%0.061%
5/29/2025Rhumbline Advisers13,006$171K0.0%+27.5%0.050%
5/23/2025Siren L.L.C.563,272$7.42M0.4%-1.6%2.170%
5/16/2025Goldman Sachs Group Inc.15,775$208K0.0%-42.7%0.061%
5/16/2025683 Capital Management LLC150,000$1.98M0.1%+20.0%0.578%
5/15/2025MPM Bioimpact LLC790,779$10.42M1.8%+9.7%3.049%
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
5/15/2025Siren L.L.C.563,272$7.42M0.4%-1.6%2.172%
5/14/2025AlphaQuest LLC7,191$95K0.0%N/A0.028%
5/14/2025Erste Asset Management GmbH260,011$3.43M0.0%+49.8%1.002%
5/13/2025Twin Focus Capital Partners LLC15,000$198K0.0%+25.0%0.058%
5/12/2025Nuveen LLC27,869$367K0.0%N/A0.107%
5/9/2025Deutsche Bank AG7,424$98K0.0%+104.1%0.029%
5/9/2025Charles Schwab Investment Management Inc.29,303$386K0.0%+9.3%0.113%
4/30/2025Alps Advisors Inc.19,392$256K0.0%-5.6%0.075%
4/29/2025Bank of New York Mellon Corp20,937$276K0.0%+7.9%0.081%
4/8/2025Rhumbline Advisers13,006$171K0.0%+27.5%0.050%
2/17/2025Two Sigma Investments LP11,812$212K0.0%-8.5%0.046%
2/17/2025MPM Bioimpact LLC721,139$12.92M1.8%+14.6%2.837%
2/17/2025Nuveen Asset Management LLC72,099$1.29M0.0%+197.8%0.284%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,786$104K0.0%+44.8%0.023%
2/17/2025Citadel Advisors LLC315,000$5.64M0.0%-16.2%1.239%
2/17/2025Bank of America Corp DE11,690$209K0.0%+54.4%0.046%
2/17/2025683 Capital Management LLC125,000$2.24M0.1%+65.7%0.492%
2/14/2025Northern Trust Corp95,030$1.70M0.0%+50.6%0.374%
2/14/2025Virtus ETF Advisers LLC3,533$63K0.0%N/A0.014%
2/14/2025MetLife Investment Management LLC6,667$119K0.0%N/A0.026%
2/13/2025Barclays PLC19,099$342K0.0%+64.5%0.075%
2/13/2025Renaissance Technologies LLC13,800$247K0.0%N/A0.054%
2/13/2025Wells Fargo & Company MN4,847$87K0.0%+112.7%0.019%
2/12/2025Geode Capital Management LLC221,257$3.96M0.0%+63.0%0.870%
2/12/2025JPMorgan Chase & Co.274,740$4.92M0.0%-11.1%1.081%
2/11/2025Corebridge Financial Inc.5,122$92K0.0%+32.6%0.020%
2/10/2025Erste Asset Management GmbH173,566$3.26M0.0%-93.6%0.683%
2/6/2025Charles Schwab Investment Management Inc.26,803$480K0.0%+40.7%0.105%
2/4/2025Bank of New York Mellon Corp19,407$348K0.0%+28.5%0.076%
1/31/2025New York State Common Retirement Fund3,902$70K0.0%-23.5%0.015%
1/30/2025Rhumbline Advisers10,201$183K0.0%+10.0%0.040%
1/27/2025Mirae Asset Global Investments Co. Ltd.4,562$82K0.0%+22.8%0.018%
1/24/2025China Universal Asset Management Co. Ltd.5,389$97K0.0%N/A0.021%
12/26/2024JPMorgan Chase & Co.309,018$4.98M0.0%+0.9%1.216%
11/19/2024Barclays PLC11,611$188K0.0%+208.6%0.046%
11/16/2024Geode Capital Management LLC135,700$2.19M0.0%+2.1%0.534%
11/15/2024Barclays PLC11,611$188K0.0%+208.6%0.046%
11/15/2024State Street Corp157,495$2.54M0.0%+2.5%0.620%
11/15/2024Ikarian Capital LLC52,193$841K0.1%-78.5%0.205%
11/13/2024Great Point Partners LLC200,000$3.22M0.9%N/A0.787%
11/13/2024BNP Paribas Financial Markets1,651$27K0.0%+122.5%0.006%
11/13/2024FMR LLC2,851,830$45.97M0.0%+458.3%11.219%
10/23/2024Lake Street Advisors Group LLC15,822$255K0.0%-50.0%0.074%
9/16/2024Point72 DIFC Ltd1,725$47K0.0%N/A0.008%
9/16/2024Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061%
9/16/2024Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009%
8/27/2024Logos Global Management LP90,000$2.43M0.2%N/A0.506%
8/15/2024Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009%
8/14/2024Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061%
8/14/2024Point72 DIFC Ltd1,725$47K0.0%N/A0.008%
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
8/14/2024Marshall Wace LLP30,038$811K0.0%N/A0.140%
8/14/2024Logos Global Management LP90,000$2.43M0.2%N/A0.421%
8/9/2024Renaissance Technologies LLC17,052$461K0.0%-96.9%0.096%
8/6/2024Lake Street Advisors Group LLC31,644$855K0.0%N/A0.178%
8/1/2024Rhumbline Advisers8,487$229K0.0%-93.5%0.048%
7/26/2024Bank of New York Mellon Corp19,916$538K0.0%-93.7%0.112%
7/22/2024Hall Laurie J Trustee1,759$48K0.0%-96.7%0.010%
5/17/2024Artal Group S.A.9,136,635$5.94M0.2%N/A171.098%
5/14/2024American International Group Inc.56,202$37K0.0%N/A1.052%
5/10/2024Vanguard Group Inc.6,315,113$4.11M0.0%N/A118.172%


RNAC Institutional Ownership - Frequently Asked Questions

During the previous two years, 57 institutional investors and hedge funds held shares of Cartesian Therapeutics. The most heavily invested institutionals were FMR LLC ($45.97M), Siren L.L.C. ($7.42M), MPM Bioimpact LLC ($7.13M), Citadel Advisors LLC ($5.64M), Vanguard Group Inc. ($5.32M), Great Point Partners LLC ($3.22M), and State Street Corp ($2.54M).Learn more on Cartesian Therapeutics' institutional investors.

86.95% of Cartesian Therapeutics' stock is owned by institutional investors. Learn more on RNAC's institutional investor holdings.

Of the 47 institutional investors that purchased Cartesian Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($2.34M), Great Point Partners LLC ($200K), 683 Capital Management LLC ($193.57K), Logos Global Management LP ($180K), Privium Fund Management B.V. ($172.50K), Marshall Wace LLP ($167.40K), and Millennium Management LLC ($164.37K).

Institutional investors have bought a total of 926,378 shares in the last 24 months. This purchase volume represents approximately $7.43M in transactions.

Of the 9 institutional investors that sold Cartesian Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: JPMorgan Chase & Co. ($188.96K), MPM Bioimpact LLC ($104.77K), XTX Topco Ltd ($16.02K), Goldman Sachs Group Inc. ($11.75K), Jacobs Levy Equity Management Inc. ($11.32K), Geode Capital Management LLC ($6.57K), and AlphaQuest LLC ($2.98K).

Institutional investors have sold a total of 345,837 shares in the last 24 months. This volume of shares sold represents approximately $3.56M in transactions.



This page (NASDAQ:RNAC) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners